QMENTA to exhibit at ECTRIMS in Berlin, RSNA in Chicago & PCT in Barcelona
We are proud to announce that we will be exhibiting at: ECTRIMS in Berlin from October 10th to October 12th, booth C12 RSNA in Chicago from November...
We are proud to announce that we will be exhibiting at: ECTRIMS in Berlin from October 10th to October 12th, booth C12 RSNA in Chicago from November...
BOSTON, MA & CAMBRIDGE, MA – QMENTA and Amylyx Pharmaceuticals today announced a collaboration to support Amylyx’s upcoming clinical trial of AMX0035...
A poor functional outcome of stroke patients may be predicted by early signs on CT and MRI. Radiology exams carried out within 6 hours after stroke...
Impact of psychiatric disorders in the world. The World Health Organization estimates that around 450 million people suffer from psychiatric...
Boston: QMENTA – The innovative platform for clinical trials and...
Stroke is the 5th leading cause of death in the world with numbers reaching up to 615.000 dead in Europe, 800.000 in the US each year. Quantib and...
QMENTA was featured in an article written by Alberto Iglesias Fraga in Business Insider Spain stating 9 innovative companies using the full potential...
This blog post first appeared on the Quantib blog on March 14, 2018. Click here for the original. Stroke is one of the most common causes of death in...